Try our beta test site
102 studies found for:    Open Studies | "Dry Eye Syndromes"
Show Display Options
Rank Status Study
21 Recruiting Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome
Condition: Dry Eye Syndromes
Interventions: Device: Thealoz Duo Eye Drops;   Device: Optive Eye Drops;   Device: Systane Ultra Eye Drops
22 Recruiting Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms
Conditions: Dry Eye Syndromes;   Blinking
Intervention: Device: Infrared oculography
23 Recruiting Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: REMOGEN OMEGA;   Device: Povidone
24 Recruiting Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: Placebo;   Other: Sham;   Drug: Cyclosporine New Ophthalmic Formulation
25 Not yet recruiting A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Drug: ISV 101
26 Recruiting Assessment of TFT by OCT in Healthy Subjects and Subjects With DES
Condition: Dry Eye Syndromes
Intervention:
27 Recruiting Clinical Evaluation of Systane® Balance in Dry Eye Subjects
Condition: Dry Eye
Intervention: Other: Propylene Glycol 0.6% eye drops
28 Not yet recruiting A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye
Condition: Dry Eye
Interventions: Device: CBL-101 Eye Drops;   Device: Vismed® Multi
29 Recruiting An 8-week Study to Evaluate Safety and Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Dry Eye
Condition: Dry Eye
Interventions: Drug: NGF;   Other: Vehicle
30 Not yet recruiting The Effect of Eyelid Surgery on Dry Eye - a Prospective Study
Conditions: Dry Eye Syndrome;   Ptosis;   Dermatochalasis
Intervention:
31 Recruiting Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Condition: Dry Eye
Interventions: Drug: OmegaD;   Drug: Placebo
32 Recruiting Ocular Surface Microbiome
Condition: Dry Eye Syndromes
Intervention:
33 Recruiting Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Device: NovaTears®;   Device: Hydrabak®
34 Recruiting Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
35 Recruiting Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Conditions: Autoimmunity;   Dry Eye Syndrome
Intervention: Other: Cross-sectional study
36 Recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
37 Recruiting Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond Laser
Conditions: Cataract;   Dry Eye
Intervention:
38 Recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation
39 Recruiting Ocular Surface Microbiome in Dry Eye Patients
Condition: Dry Eye
Intervention:
40 Not yet recruiting PILOT STUDY FOR TESTING SAFETY OF REPETITIVE MAGNETIC STIMULATION FOR TREATMENT OF DRY EYE
Condition: Dry Eye
Intervention: Device: repeated magnetic stimulation (RMS) treatment to the eye

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.